At a Glance
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC founded in 2000. Hatteras Venture Partners is a healthcare venture capital firm investing in biotech, medtech, and healthtech companies advancing patient care. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Notable portfolio companies include MetricStream, Bandwidth, Bronto and Spreedly. Invests in early-stage technology companies in the Southeast, particularly in enterprise software and healthcare IT.
“Invests in early-stage biotechnology, medical device and health technology companies, primarily in North Carolina and the wider Southeast.”
The general partner group is John Crumpler, Clay B. Thorp, Christy Shaffer PhD and Douglas Reed MD, all of whom appear as executive officers across the Fund IV through Fund VII Form D filings. Robert Ingram, who signed on through Fund VI, is memorialised on the firm's site. Michael Dial and Jeffrey Terrell joined as executive officers from Fund VI onward.
Below them, Ben Scruggs PhD and Kseniya Simpson PhD are partners, and Lauren P. Flickinger is partner and fund manager. Kim Hodges is chief financial officer and Parker Johnson heads investor relations. Venture partners are Kenneth B. Lee Jr., Fred Goldwater, Holden Thorp and Myla Lai-Goldman MD; Heather Madsen PhD is operating partner and Alston Gardner special advisor. The bench is deliberately clinical and scientific, weighted toward physicians, PhDs and former healthcare operators rather than generalist investors.
Hatteras has raised seven funds over more than twenty-five years and about 100 companies, with Form D filings documenting the last four. Fund IV filed a $125 million offering and sold $74.89 million, first sale 10 August 2011, from Raleigh. Fund V filed $150 million and sold $91.12 million, first sale 7 August 2015, from Durham. Fund VI filed $250 million and sold $137.3 million, first sale 1 April 2019. Fund VII filed $250 million and had sold $135.05 million as of September 2023, against a first sale on 22 December 2021.
Alongside the flagships sit Hatteras VC Co-Investment Fund II, Hatteras Opportunity Fund I from 2022, and a 2025 vehicle, Hatteras CREATE SF SPV. Each fund is advised by a numbered entity, Hatteras Venture Advisors IV through VII, with V, VI and VII currently active on the SEC adviser registry; the registry also records Catalysta Ventures, LLC as a former name. The firm invests exclusively in biotech, medtech and healthtech.
Hatteras Venture Partners primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Hatteras Venture Partners is headquartered in Durham, NC. Many of their portfolio companies are also based in this region, though they invest across geographies.
Hatteras Venture Partners focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
Hatteras Venture Partners's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
Running a fund like Hatteras Venture Partners? Independent guides to the software and processes emerging managers use to operate.
Best Fund Administration Software
Independent breakdown of fund administration platforms by fund size.
LP Reporting Software
Tools for capital account statements and investor updates.
Portfolio Monitoring Tools
How GPs track company performance across the portfolio.
VC CRM Software
Deal-flow and relationship management for investors.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.